Your browser doesn't support javascript.
loading
RAAS blockers in hypertension posing a higher risk toward the COVID-19.
Singh, Yogendra; Gupta, Gaurav; Satija, Saurabh; Negi, Poonam; Chellappan, Dinesh K; Dua, Kamal.
Afiliação
  • Singh Y; Mahatma Gandhi College of Pharmaceutical Sciences, Jaipur, India.
  • Gupta G; School of Pharmacy, Suresh Gyan Vihar University, Jaipur, India.
  • Satija S; Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney (UTS), Sydney, New South Wales, Australia.
  • Negi P; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
  • Chellappan DK; School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, India.
  • Dua K; Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.
Dermatol Ther ; 33(4): e13501, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32359088

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Sistema Renina-Angiotensina / Inibidores da Enzima Conversora de Angiotensina / Infecções por Coronavirus / Bloqueadores do Receptor Tipo 1 de Angiotensina II / Pandemias / Betacoronavirus Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Sistema Renina-Angiotensina / Inibidores da Enzima Conversora de Angiotensina / Infecções por Coronavirus / Bloqueadores do Receptor Tipo 1 de Angiotensina II / Pandemias / Betacoronavirus Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article